Back to Search
Start Over
Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
- Source :
- Revista da Sociedade Brasileira de Medicina Tropical, Vol 49, Iss 6, Pp 774-776, Revista da Sociedade Brasileira de Medicina Tropical, Volume: 49, Issue: 6, Pages: 774-776, Published: DEC 2016
- Publication Year :
- 2016
- Publisher :
- FapUNIFESP (SciELO), 2016.
-
Abstract
- INTRODUCTION: Intralesional treatment for cutaneous leishmaniasis has been applied for over 30 years at the Oswaldo Cruz Foundation, Rio de Janeiro, with good therapeutic results and without relevant systemic toxicity. METHODS Meglumine antimoniate was injected subcutaneously, using a long medium-caliber needle (for example, 30mm × 0.8mm); patients received 1-3 injections, with 15-day intervals. RESULTS The technique is described in detail sufficient to enable replication. CONCLUSIONS: The treatment of cutaneous leishmaniasis with intralesional meglumine antimoniate is a simple, effective, and safe technique, which may be used in basic healthcare settings.
- Subjects :
- 0301 basic medicine
Microbiology (medical)
medicine.medical_specialty
lcsh:Arctic medicine. Tropical medicine
lcsh:RC955-962
Meglumine antimoniate
030106 microbiology
030231 tropical medicine
Antiprotozoal Agents
Leishmaniasis, Cutaneous
Injections, Intralesional
Therapy meglumine antimoniate
Intralesional technique
03 medical and health sciences
Meglumine
0302 clinical medicine
Cutaneous leishmaniasis
Organometallic Compounds
medicine
Humans
Meglumine Antimoniate
business.industry
American cutaneous leishmaniasis
Leishmaniasis
medicine.disease
Surgery
Infectious Diseases
Systemic toxicity
Healthcare settings
Parasitology
business
medicine.drug
Subjects
Details
- ISSN :
- 00378682
- Volume :
- 49
- Database :
- OpenAIRE
- Journal :
- Revista da Sociedade Brasileira de Medicina Tropical
- Accession number :
- edsair.doi.dedup.....bfac0068d9a17c3a0faa9a1947e0c60c